A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities

MLA

Leila Dorling, et al. A Nested Cohort Study of 6,248 Early Breast Cancer Patients Treated in Neoadjuvant and Adjuvant Chemotherapy Trials Investigating the Prognostic Value of Chemotherapy-Related Toxicities. Sept. 2016. EBSCOhost, https://doi.org/10.17863/cam.4823.

APA

Leila Dorling, Sarah Bowden, Helena M. Earl, Susan Ingle, Louise Hiller, Linda Jones, Anne-Laure Vallier, Carlos Caldas, Janet A. Dunn, Paul D.P. Pharoah, Jean Abraham, Chris Twelves, Richard R. Hardy, & Christopher J. Poole. (2016). A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. https://doi.org/10.17863/cam.4823

Chicago

Leila Dorling, Sarah Bowden, Helena M. Earl, Susan Ingle, Louise Hiller, Linda Jones, Anne-Laure Vallier, et al. 2016. “A Nested Cohort Study of 6,248 Early Breast Cancer Patients Treated in Neoadjuvant and Adjuvant Chemotherapy Trials Investigating the Prognostic Value of Chemotherapy-Related Toxicities,” September. doi:10.17863/cam.4823.